Loading
Total declarations
Companies
▲ Purchases (291 ops.)
▼ Sales (2 ops.)
Latest filing published 12 Oct 2026 for Dawnrays Pharmaceutical (Holdings) Ltd., €6,536.
Filing timeline
BuySaleHung Yung Lai
First 200 filings with a declared amount
Insider track record
Disclosed buys
291
Disclosed sells
2
Signal history
Closed purchases
Market purchases
291
Positive at T+90
29%
Median T+90
-5.7%
Based on 270 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -1.0%Entry HK$0.95 · Close 23 Oct 2026 HK$0.94
- -1.6%Entry HK$0.96 · Close 23 Oct 2026 HK$0.94
- -3.1%Entry HK$0.98 · Close 23 Oct 2026 HK$0.94
- -6.0%Entry HK$1.00 · Close 23 Oct 2026 HK$0.94
- -7.4%Entry HK$1.02 · Close 23 Oct 2026 HK$0.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Hung Yung Lai: trading record in brief
This profile gathers the share dealings of Hung Yung Lai across 2 companies, led by Dawnrays Pharmaceutical (Holdings) Ltd. and Sing Lee Software (Group) Ltd. In total, 305 filings cover trades dated from 28 March 2018 to 9 October 2026.
In open-market terms, that means 291 purchases worth €3.4M on one side and 2 sales worth €380k on the other. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 20 purchases and no sales on the market.
Half of the purchases are above €8,069 and half below. As a share of market capitalisation, the median purchase stands at 0.0046%, based on 20 purchases. On 254 out of 289 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 270 purchases show a median change of -5.7%, with the price up in 29% of them. This is a record of the past, not a forecast.
The record was last updated on 12 October 2026 with an open-market purchase (€6,536) in Dawnrays Pharmaceutical (Holdings) Ltd. Typically, a trade is published a median of 1 day after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Hung Yung Lai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations295 total
60,000 shares@ HK$0.960.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00694
Canonical exit: 7 Jan 2027 (T+90)
60,000 shares@ HK$0.9650.0040% mcap4.1% of flowShareXHKGHKEX:DA20261009E00693
Canonical exit: 5 Jan 2027 (T+90)
84,000 shares@ HK$0.96670.0056% mcap6.3% of flowShareXHKGHKEX:DA20261007E00013
Canonical exit: 3 Jan 2027 (T+90)
172,000 shares@ HK$0.9730.011% mcap13.7% of flowShareXHKGHKEX:DA20261002E00168
Canonical exit: 29 Dec 2026 (T+90)
96,000 shares@ HK$0.9760.0064% mcap8.9% of flowShareXHKGHKEX:DA20260930E00015
Canonical exit: 28 Dec 2026 (T+90)
96,000 shares@ HK$0.9750.0063% mcap8.8% of flowShareXHKGHKEX:DA20260930E00013
Canonical exit: 27 Dec 2026 (T+90)
76,000 shares@ HK$0.9850.0051% mcap5.9% of flowShareXHKGHKEX:DA20260924E00334
Canonical exit: 22 Dec 2026 (T+90)
92,000 shares@ HK$0.9750.0061% mcap7.0% of flowShareXHKGHKEX:DA20260924E00328
Canonical exit: 21 Dec 2026 (T+90)
64,000 shares@ HK$0.97880.0042% mcap4.9% of flowShareXHKGHKEX:DA20260922E00308
Canonical exit: 20 Dec 2026 (T+90)
104,000 shares@ HK$0.9950.0069% mcap11.6% of flowShareXHKGHKEX:DA20260911E00703
Canonical exit: 9 Dec 2026 (T+90)
104,000 shares@ HK$1.000.0069% mcap11.7% of flowShareXHKGHKEX:DA20260905E00056
Canonical exit: 2 Dec 2026 (T+90)
60,000 shares@ HK$0.990.0040% mcap6.7% of flowShareXHKGHKEX:DA20260905E00057
Canonical exit: 3 Dec 2026 (T+90)
72,000 shares@ HK$1.000.0049% mcap8.3% of flowShareXHKGHKEX:DA20260626E00360
Canonical exit: 23 Sept 2026 (T+90)
36,000 shares@ HK$1.130.0027% mcap4.6% of flowShareXHKGHKEX:DA20260514E00650
Canonical exit: 12 Aug 2026 (T+90)
52,000 shares@ HK$1.150.0039% mcap6.7% of flowShareXHKGHKEX:DA20260508E00513
Canonical exit: 5 Aug 2026 (T+90)
8,000 shares@ HK$1.120.0006% mcap1.0% of flowShareXHKGHKEX:DA20260423E00021
Canonical exit: 20 Jul 2026 (T+90)
44,000 shares@ HK$1.120.0032% mcap5.5% of flowShareXHKGHKEX:DA20260416E00055
Canonical exit: 14 Jul 2026 (T+90)
20,000 shares@ HK$1.130.0015% mcap2.5% of flowShareXHKGHKEX:DA20260415E00002
Canonical exit: 12 Jul 2026 (T+90)
40,000 shares@ HK$1.140.0030% mcap5.1% of flowShareXHKGHKEX:DA20260403E00005
Canonical exit: 30 Jun 2026 (T+90)
84,000 shares@ HK$1.090.0060% mcap10.5% of flowShareXHKGHKEX:DA20260331E00419
Canonical exit: 28 Jun 2026 (T+90)
8,000 shares@ HK$1.170.0% of flowShareXHKGHKEX:DA20251126E00407
Canonical exit: 22 Feb 2026 (T+90)
60,000 shares@ HK$1.180.3% of flowShareXHKGHKEX:DA20251113E00002
Canonical exit: 9 Feb 2026 (T+90)
60,000 shares@ HK$1.200.3% of flowShareXHKGHKEX:DA20251107E00501
Canonical exit: 4 Feb 2026 (T+90)
52,000 shares@ HK$1.220.3% of flowShareXHKGHKEX:DA20251105E00011
Canonical exit: 1 Feb 2026 (T+90)
60,000 shares@ HK$1.210.3% of flowShareXHKGHKEX:DA20251101E00003
Canonical exit: 28 Jan 2026 (T+90)
25 of 295 declarations
